When Titans Fall: A Wildean Ode to Contrarian Alchemy 🦋

by

Behold the theater of modern finance: where one man’s ruin becomes another’s portfolio highlight. Cooper Creek Partners, that most fastidious of New York’s moneyed aesthetes, has acquired a $63.1 million parcel of Chemours shares-a company whose stock, like a fallen aristocrat, languishes at 80% below its 2017 splendor. One might say the market has lost its taste for titanium dioxide, though not for drama.

The Aesthetic of Decline

The filing, delivered with November’s melancholy, reveals a 4-million-share acquisition spree. Let us not call it a “position”-such vulgarity!-but rather a curated collection, representing 1.9% of their 13F gallery. To lose 41% in a year, as Chemours has, is a misfortune; to lose 80% since 2017 suggests a certain artistic commitment to tragedy. Yet Cooper Creek, ever the connoisseur of undervalued narratives, sees “value” where others see vacancy.

On the Vanity of Metrics

Consider the numbers, though numbers are such tedious things. Revenue: $5.8 billion, trailing like a dusty train. Net income: a deficit of $320 million, which the company has managed to transform into $60 million of profit through the alchemy of quarterly reporting. Dividend yield: 2.7%, a modest bouquet for those who collect such curiosities. The share price: $12.79, a figure so precise it borders on satire.

The Alchemist’s Canvas

Chemours, you see, is no mere chemical concern. It peddles “advanced performance materials” and refrigerants under brands like Ti-Pure-a name that whispers of both purity and pretension. Its clients? The glitterati of industry: automotive, electronics, water treatment. One imagines its executives in Savile Row suits, lamenting the collapse of titanium dioxide demand between sips of absinthe.

The Fool’s Epiphany

Why this dalliance with despair? Cooper Creek’s wager suggests a belief that even cyclical melancholy must end. The third-quarter results, flat as a society portrait, revealed “operational stability”-a phrase that sounds less thrilling than it ought. Yet in a world where industrial demand is as fickle as fashion, any stability becomes a kind of revolution.

Wilde’s Investment Adage

Let us remember: the market is merely a stage where actors don the masks of bulls and bears. To buy Chemours today is to collect Rembrandts at a bankruptcy auction-assuming, of course, the Rembrandt in question still owes its creditors. The fund’s 1.9% allocation is both a whisper and a challenge: “Gaze upon this wreckage, and tell me you don’t see a phoenix.”

Glossary for the Uninitiated

13F reportable assets: The stock market equivalent of a guest list-only the names matter, not the reasons they’re there.
Assets under management (AUM): The total wealth a fund pretends to care about.
Position: A carefully curated bet, lest we use the vulgar term “gamble.”
Dividend yield: The faint pulse of hope in a dying stock.
Trailing twelve months (TTM): The financial equivalent of counting yesterday’s roses.

And thus, dear reader, we find ourselves at the intersection of ruin and reinvention. For those who dare to invest where others dare not look, remember: every bankruptcy is a sonnet waiting to be written. 🦋

Read More

2025-12-01 00:12